[This corrects the article DOI: 10.1155/2018/9852791.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481153 | PMC |
| http://dx.doi.org/10.1155/2019/9598038 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum to "Targeted mupirocin-based decolonization for Staphylococcus aureus carriers and the subsequent risk of mupirocin resistance in haemodialysis patients - a longitudinal study over 20 years" [J Hosp Infect 135 (2023) 55-58].
J Hosp Infect
January 2025
Infection Control Program, Geneva University Hospitals and Faculty of Medicine, WHO Collaborating Center, Geneva, Switzerland.
Corrigendum to 'A dual-targeted electrochemical aptasensor for neuroblastoma-related microRNAs detection' [Talanta, Volume 280, (2024) 126772].
Talanta
January 2025
Medical College, Tianjin University, Tianjin, 300072, China. Electronic address:
Retraction notice to "Corrigendum to 'Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer' [International Journal of Biological Macromolecules 248 (2023) 125782]".
Int J Biol Macromol
January 2025
Institute of Biomedical Sciences, College of Medicine, National Sun Yat-sen University, Kaohsiung 80424, Taiwan; Department of Mechanical and Electro-Mechanical Engineering, National Sun Yat-sen University, Kaohsiung 80424, Taiwan.
Corrigendum: Pyroglutamyl aminopeptidase 1 is a potential molecular target toward diagnosing and treating inflammation.
Front Immunol
December 2024
The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
[This corrects the article DOI: 10.3389/fimmu.2023.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!